Intravenous (IV) iron therapy is more effective than oral drugs for women with anemia and heavy periods, providing better ...
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding ...
News-Medical.Net on MSN
IV iron dextran more cost-effective than oral iron for women with heavy menstrual bleeding and IDA
A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in Blood ...
Mitapivat is the first FDA-approved oral therapy for anaemia in all forms of thalassemia Reduced transfusion dependence may ...
(WASHINGTON, Jan. 8, 2026) — A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new ...
With a $125 million series B financing round, Diagonal Therapeutics has made a vertical move to advance its first-in-class ...
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...
IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate.
MedPage Today on MSN
Autoimmune Anemia Is the Latest Condition Found Responsive to CAR-T Therapy
Initial results as promising as those in lupus and other non-cancer diseases driven by B c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback